News Archive

No Comments

PregTech invited to AusBiotech Global Investment Event Series

Preg Tech has been invited to attend the 2016 AusBiotech Global Investment Event Series, with events taking place in Asia. Director Jack Ducat will be giving a Company Spotlight Presentation on the LuteiMate project to the attendees at the conferenceThis event will connect life science investors with biotech and medtech innovators from across the globe to discuss investment and partnership opportunities.

Events in the series include:

Singapore Biotech Invest, Singapore Exchange
3 May 2016

Asia Biotech Invest, Hong Kong Convention and Exhibition Centre
5 – 6 May 2016

Preg Tech will be attending both the Singapore and Hong Kong Events. Please take this opportunity to come and meet Jack Ducat and Michael Kleinig and discuss our exciting project. Details on these events and program can be found at http://ausbiotechinvestment.com.au/

No Comments

New director joins board of Pregtech

The board of Pregtech Pty Ltd is pleased to announce the appointment of Mr Michael Kleinig as a Director.

Mr Michael Kleinig has been involved in product research and business development, mainly in the biotechnology space, for over 20 years. Over the past 10 years, he has held the position of CEO at three private biotechnology companies. Previously he held senior executive positions at Clinuvel Limited (ASX–CUV) as well as senior management roles at Australia’s largest pharmaceutical company, CSL Limited (ASX–CSL). He is also the Principal of a private Pharmaceutical / Business Development / Management consulting company as well the Executive Director of Go Resources Pty Ltd.

To read more about Michael’s background please CLICK HERE.

No Comments

PregTech wins commercialisation grant

Today Commercialisation Australia announced that PregTech was to be the recipient of an Accelerating Commercialisation grant.

We received this grant for the Skills and Knowledge component of the AC Grant Program. The total project was $50,000 and the money was used to acquire specialist Commercialisation Services, for Regulatory Strategy Development, Marketing Research Work and the Development of Capital Raising Strategy.

For further details about the AC Grant received by PregTech please CLICK HERE.